Torus Biosystems Previews Orbit PCR™ at IDWeek™

qPCR redefined to advance research and innovation MEDFORD, Mass.–(BUSINESS WIRE)–Torus Biosystems (“Torus” or the “Company”) today announced that it would be introducing Orbit PCR™ for Research Use Only (RUO) applications at IDWeek™ in Washington, DC. Using Orbit PCR, researchers can identify 300+ nucleic acid target sequences per sample within 30 minutes. Orbit PCR is possible … [Read more…]

CFK Africa Expands its Programs to 25 Informal Settlements Across Kenya

Nonprofit begins scaling successful initiatives driven by its model of participatory development NAIROBI, Kenya–(BUSINESS WIRE)–#africa—CFK Africa, a nonprofit with offices in Kenya and the U.S., is using a participatory model to expand its successful programs from Kibera into 25 additional informal settlements in eight of the 47 counties across Kenya. In 2021, after marking its 20th … [Read more…]

SpikImm, a Biotechnology Company Founded by Truffle Capital Under License from the Institut Pasteur, Announces that the Clinical Trials for SPK001, its Monoclonal Antibody Against SARS-COV-2, Have Begun

This Clinical Trial Has Been Awarded National Priority Research Status by the French Government PARIS–(BUSINESS WIRE)–SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by the Institut Pasteur’s Human Immunology Laboratory, directed by Dr. Hugo Mouquet (Inserm Joint Research Unit), has been tested on … [Read more…]

Xeris Biopharma Announces Positive Topline Phase 1 Clinical Data of Its Investigational Subcutaneous (SC) Levothyroxine (XP-8121); Hosts Conference Call and Webcast

Data demonstrate proof-of-concept showing a once weekly subcutaneous injection of XP-8121 provides similar exposure at steady-state as daily oral Synthroid® Simulation model implies dose conversion factor of 4X XP-8121 in healthy volunteers was generally well tolerated at all doses Data supports further development in patients with congenital or acquired hypothyroidism who require thyroid hormone replacement … [Read more…]

Biodesix to Report Third Quarter 2022 Financial Results on November 3, 2022

BOULDER, Colo.–(BUSINESS WIRE)–$BDSX #patientsfirst—Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus on lung disease, today announced that it will release financial results for the third quarter ended September 30, 2022 before the open of trading on Thursday, November 3. Biodesix’s management will host a conference call and webcast to discuss … [Read more…]

Cerba and Taliaz to Leverage Artificial Intelligence and Genetics Expertise to Improve Patient Care Management in Depression

SAINT OUEN L’AUMÔNE, France & TEL AVIV, Israel–(BUSINESS WIRE)–Cerba, the foremost specialty clinical pathology reference, and Taliaz, an Israeli digital health company dedicated to improving mental health disorders, announced today a partnership to provide physicians with an AI-driven precision psychiatry solution that predicts treatment effectiveness in depression. By finding the right treatment from the very … [Read more…]

Hevolution Foundation Launches Grants Program to Encourage Research into the Science of Aging in Saudi Arabia

Pilot Program Will Issue Grants of up to 500,000 Saudi Riyals to Local Researchers RIYADH, Saudi Arabia–(BUSINESS WIRE)–#agingresearch—Hevolution Foundation, a non-profit organization that provides grants and early-stage investments to incentivize research and entrepreneurship in healthspan science, announces a new grants program to encourage research into the aging process in Saudi Arabia, as part of the … [Read more…]

AM-Pharma Provides Business Update and Outcome of Pre-planned Interim Futility Analysis of Phase 3 REVIVAL Study

Phase 3 REVIVAL study stopped per recommendation of data monitoring committee after per-protocol pre-specified interim futility analysis on the study’s primary endpoint, 28-day mortality, without any safety concern. A significant reduction in Major Adverse Kidney Events by day 90 and no difference in overall mortality was observed after review of the data for all 649 … [Read more…]

Patient Centric Healthcare App Global Market Report 2022: Enhanced Access and Flexibility with Novel Technologies Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Patient Centric Healthcare App Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to ResearchAndMarkets.com’s offering. The global patient centric healthcare app market is expected to grow at a CAGR of around 21.9% during 2022-2028. This report on global patient centric healthcare app market report provides holistic understanding of … [Read more…]

University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs

TÜBINGEN, Germany & INGELHEIM, Germany–(BUSINESS WIRE)–University of Tübingen, a leading member of Cyber Valley, Europe’s largest Artificial Intelligence (AI) research consortium and Boehringer Ingelheim launch an AI and data science fellowship program for top talents from around the world. Three to five fellowships will be awarded per year for up to three years with a … [Read more…]